ZYVERSA THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Units
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Stock Issued During Period, Value, Conversion of Units of $719.08 thousand for the 9-month period ending 2021-12-31, per its 10-K filed 2022-04-15.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodValueConversionOfUnits · last filed 2022-04-15
- 2021-12-31: Stock Issued During Period, Value, Conversion of Units 9 month $719.08K.
| Period end | Stock Issued During Period, Value, Conversion of Units 9 month |
|---|---|
| 2021-12-31 | $719.08K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |